Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Cortexyme, Inc. (CRTX) InvestigationBusiness Wire • 01/27/22
SHAREHOLDER ALERT: Investigation of Cortexyme, Inc. (CRTX) Announced by Holzer & Holzer, LLCNewsfile Corp • 01/26/22
Cortexyme Announces Clinical Hold on Atuzaginstat's Investigational New Drug ApplicationBusiness Wire • 01/26/22
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The LeaderboardBenzinga • 12/06/21
Is the Options Market Predicting a Spike in Cortexyme (CRTX) Stock?Zacks Investment Research • 12/01/21
Cortexyme to Present at 4th Annual Evercore ISI HealthCONx Conference on November 30thBusiness Wire • 11/23/21
Cortexyme's Atuzaginstat Slowed Cognitive Decline in Participants With Alzheimer's Disease and P. Gingivalis Infection in Phase 2/3 GAIN Trial: Additional Top-line Data Presented at CTAD 2021Business Wire • 11/11/21
Cortexyme to Present Additional Top-line GAIN Trial Results and Analysis at CTAD 2021 on November 11thBusiness Wire • 11/04/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Cortexyme, Inc. - CRTXPRNewsWire • 11/04/21